Novo Nordisk and Valo Health expand AI partnership to tackle cardiometabolic diseases

Novo Nordisk and Valo Health have strengthened their collaboration to advance AI-driven drug discovery, targeting major cardiometabolic diseases, including obesity, type 2 diabetes, and cardiovascular ... Read More